Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream - 24/08/11
Monterrey, Mexico, and Miami, Florida
Abstract |
Ten patients with superficial infantile hemangiomas were treated with imiquimod 5% cream for up to 16 weeks. Four patients achieved complete clinical resolution, 3 had excellent improvement, one showed moderate improvement, and one patient did not respond to therapy. Imiquimod may be an effective alternative for the treatment of superficial hemangiomas.
Le texte complet de cet article est disponible en PDF.Plan
This study was approved by the research and ethical committee of the post-graduate medical school UANL. Imiquimod 5% cream was donated for the patients by 3M Pharmaceuticals in Monterrey, Mexico. Dr Berman is a consultant for, a member of the speakers bureau of, and has received education grants from 3M Pharmaceuticals. |
Vol 51 - N° 4
P. 639-642 - octobre 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?